课题基金 / 基金详情

项目摘要

项目成果

Steffi Oesterreich的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We originally cloned SAFB1 as a transcriptional repressor, and it has since been implicated in a number of cellular processes including stress response, apoptosis, RNA processing, hormone response, immortalization, and transformation. During the last funding period we performed detailed structure function studies which identified a transcriptional repression domain, we found that sumoylation of SAFB1 was necessary for its co-repressor activity, and finally, we generated and characterized SAFB1-null mice which showed prenatal and neonatal lethality with surviving mice showing dramatic defects in the development and function of the reproductive system. To gain more insight into SAFB1's role in ERalpha action, we performed an unbiased screen using SAFB1 siRNA knockdown followed by microarray analysis. This experiment revealed a significant role for SAFB1 in estrogen-mediated repression of gene expression, and candidate genes that require SAFB1 for estrogen-mediated downregulation were identified. Here we propose to study how SAFB1 mediates estrogen repression of gene expression. Specifically, we will i) determine how SAFB1 SAFB1 mediates transcriptional repression of estrogen-responsive target genes, ii) characterize HDAC7 as a critical player in SAFB1-mediated repression of estrogen regulated genes, and iii) determine how posttranslational modification by sumoylation affects SAFB1's co-repressor function. This work is highly significant since it provides studies of fundamental mechanisms which may contribute to a change in paradigm of ERalpha's action. While ERalpha has mainly been studied as a transcriptional activator, the study of estrogen- mediated repression of gene expression, and in particular the role of co-repressors, is an understudied area. 1
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/onc.2013.294
发表时间: 2014-06-19
期刊: Oncogene
影响因子: 8
作者: []
通讯作者:
Using mice to treat (wo)men: mining genetic changes in patient xenografts to attack breast cancer.
使用小鼠治疗男性(女性):挖掘患者异种移植物中的基因变化来攻击乳腺癌。
DOI: 10.1016/j.celrep.2013.09.008
发表时间: 2013
期刊: Cell reports
影响因子: 8.8
作者: [Oesterreich,Steffi, Brufsky,AdamM, Davidson,NancyE]
通讯作者: Davidson,NancyE
DOI: 10.1002/jcb.10685
发表时间: 2003-11-01
期刊: JOURNAL OF CELLULAR BIOCHEMISTRY
影响因子: 4
作者: [Oesterreich, S]
通讯作者: Oesterreich, S
DOI: 10.1016/j.bbrc.2011.04.040
发表时间: 2011-05-20
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Garee JP, Meyer R, Oesterreich S]
通讯作者: Oesterreich S
6
    2019 Hormone-Dependent Cancers Gordon Research Conference and Gordon Research Seminar
    • 批准号:
      9760128
    • 项目类别:
    • 资助金额:
      $0.7万
    • 财政年份:
      2019
    • 负责人:
      Steffi Oesterreich
    • 依托单位:
    Mechanism-based strategies to target ER-mutant endocrine resistant breast cancer
    Mechanism-based strategies to target ER-mutant endocrine resistant breast cancer
    FGFR4: A druggable mediator of endocrine resistance in breast cancer
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: